ES
Director, Partnerships & Strategy
Get the full picture
Sign in to uncover key details.
SeraGene Therapeutics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2405 Wesbrook Mall Fl 4, Vancouver, Brit...Website
www.seragenetx.comRevenue
<$5 MillionIndustry
About SeraGene Therapeutics
SeraGene Therapeutics is a pre-clinical stage biotech company focused on innovating treatments for coagulation disorders using RNA and nanomedicine technologies. The company aims to provide long-lasting control over coagulation issues with therapies designed for lifelong use, enhancing the quality of life for patients. Their portfolio includes developing prophylactic therapies for rare bleeding disorders, enhancing transfusable platelets, and managing thrombotic disorders. SeraGene is particularly dedicated to addressing the needs of women and girls affected by bleeding disorders.Explore more
SeraGene Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to SeraGene Therapeutics
Compare insights from companies similar to SeraGene Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SeraGene Therapeutics
<$5M
11-50
Private
-
2022
KB
Katherine BadiorDirector, Research & Co-Founder, Development
SeraGene Therapeutics Tech Stack
A closer look at the technologies used by SeraGene Therapeutics
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SeraGene Therapeutics
Sign Up For FreeTo access detailed company insights
SeraGene Therapeutics is a pre-clinical stage biotech company focused on innovating treatments for coagulation disorders using RNA and nanomedicine technologies. The company aims to provide long-lasting control over coagulation issues with therapies designed for lifelong use, enhancing the quality of life for patients. Their portfolio includes deve... Read More
